一个联合SSRI和抗炎治疗的计算帐户
Melissa Reneaux1,2, Helen Mayberg3, Karl Friston4
1Centre for Mathematical Neuroscience and Psychology and Department of Psychology, City St. George's -University of London, London, United Kingdom.
Frontiers in immunology
|May 12, 2025
概括
一个新的计算模型揭示了炎症在抑郁症中的作用. 对于严重的抑郁症,复苏需要联合抗抑郁药和抗炎药治疗,而不是较轻的病例.
科学领域:
- 计算神经科学是一种计算神经科学.
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
背景情况:
- 抑郁症影响全球数百万人,慢性病例通常与炎症有关.
- 现有的抑郁症治疗方法可能对某些患者无效,特别是那些患有炎症相关慢性病的人.
- 炎症在大脑的血清系统中的作用及其对抑郁症严重性的影响需要进一步理解机制.
研究的目的:
- 开发一种计算模型,阐明炎症,血清激素水平和抑郁症中大脑活动之间的相互作用.
- 研究炎症如何影响前额叶皮层 (PFC) 和下带皮层 (SCC) 等特定区域的血清激素度和大脑动态.
- 根据抑郁症的严重程度,评估单独和组合的抗炎和抗抑郁药物的疗效.
主要方法:
- 开发一个模拟免疫标记 (炎症),神经递质水平 (血清素) 和神经活动之间的相互作用的计算模型.
- 该模型结合了与抑郁相关的关键大脑区域 (PFC,SCC) 内的动态.
- 模拟药物干预,包括单独和联合的抗炎和抗抑郁药物治疗.
主要成果:
- 该模型展示了炎症如何影响细胞外血,以及大脑活动如何相互影响血水平.
- 对于轻度至中度抑郁症,单独的抗抑郁药物或抗炎药物使血清素和大脑活动正常化.
- 对于严重的抑郁症,只有联合服用抗抑郁药和抗炎药才能有效地使血清激素水平和大脑活动正常化.
结论:
- 这项研究为了解免疫系统,炎症和抑郁症之间的联系提供了一个机制框架.
- 这些发现强调了基于抑郁症严重程度的治疗疗法的差异性疗效,强调了严重病例需要联合治疗的必要性.
- 该模型作为进一步研究免疫系统向抑郁症治疗的基础.
相关概念视频
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
239
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
239
01:23Antidepressant Drugs: MAOIs and Other Agents
165
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
165
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
01:30Combined Effects of Drugs: Antagonism
8.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.1K
01:14Agonism and Antagonism: Quantification
262
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
262
01:20The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K